BAMF
BI Asset Management Fondsmaeglerselskab Portfolio holdings
AUM
$10.2B
1-Year Return
26.9%
This Quarter Return
-2.13%
1 Year Return
+26.9%
3 Year Return
+101.23%
5 Year Return
+181.82%
10 Year Return
+407.9%
AUM
$8.88B
AUM Growth
-$602M
(-6.4%)
Cap. Flow
-$170M
Cap. Flow
% of AUM
-1.92%
Top 10 Holdings %
Top 10 Hldgs %
34.69%
Holding
958
New
211
Increased
254
Reduced
421
Closed
49
Top Buys
| 1 |
Cisco
CSCO
|
$42.6M |
| 2 |
Microsoft
MSFT
|
$38.6M |
| 3 |
Costco
COST
|
$36.7M |
| 4 |
Automatic Data Processing
ADP
|
$31.3M |
| 5 |
Cencora
COR
|
$23.9M |
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
$44.2M |
| 2 |
Coca-Cola
KO
|
$33.2M |
| 3 |
Micron Technology
MU
|
$29.6M |
| 4 |
Tesla
TSLA
|
$26.5M |
| 5 |
IBM
IBM
|
$24.3M |
Sector Composition
| 1 | Technology | 32.81% |
| 2 | Financials | 13.9% |
| 3 | Healthcare | 11.81% |
| 4 | Consumer Discretionary | 11.48% |
| 5 | Communication Services | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Rhythm Pharmaceuticals
RYTM
$6.78B
| $34K | ﹤0.01% |
+648
| New | +$34K |
|
877
Beam Therapeutics
BEAM
$2.11B
| $33K | ﹤0.01% |
+1,714
| New | +$33K |
|
878
Mirum Pharmaceuticals
MIRM
$3.82B
| $33K | ﹤0.01% |
+727
| New | +$33K |
|
879
United Bankshares
UBSI
$5.42B
| $33K | ﹤0.01% |
+960
| New | +$33K |
|
880
Cinemark Holdings
CNK
$2.98B
| $32K | ﹤0.01% |
+1,294
| New | +$32K |
|
881
Hancock Whitney
HWC
$5.32B
| $32K | ﹤0.01% |
+612
| New | +$32K |
|
882
Bank OZK
OZK
$5.9B
| $32K | ﹤0.01% |
+744
| New | +$32K |
|
883
Sweetgreen
SG
$1.06B
| $32K | ﹤0.01% |
+1,260
| New | +$32K |
|
884
Scholar Rock
SRRK
$3.02B
| $32K | ﹤0.01% |
+990
| New | +$32K |
|
885
Upstart Holdings
UPST
$6.44B
| $31K | ﹤0.01% |
673
-1,837
| -73% | -$84.6K |
|
886
Oscar Health
OSCR
$5.02B
| $30K | ﹤0.01% |
+2,321
| New | +$30K |
|
887
Tarsus Pharmaceuticals
TARS
$2.43B
| $30K | ﹤0.01% |
+579
| New | +$30K |
|
888
Zeta Global
ZETA
$4.5B
| $30K | ﹤0.01% |
+2,179
| New | +$30K |
|
889
Ameris Bancorp
ABCB
$5.08B
| $28K | ﹤0.01% |
+487
| New | +$28K |
|
890
International Bancshares
IBOC
$4.45B
| $28K | ﹤0.01% |
+444
| New | +$28K |
|
891
Lazard
LAZ
$5.32B
| $27K | ﹤0.01% |
+632
| New | +$27K |
|
892
Associated Banc-Corp
ASB
$4.42B
| $26K | ﹤0.01% |
+1,164
| New | +$26K |
|
893
BancFirst
BANF
$4.47B
| $26K | ﹤0.01% |
+236
| New | +$26K |
|
894
Edgewise Therapeutics
EWTX
$1.64B
| $26K | ﹤0.01% |
1,163
-7,690
| -87% | -$172K |
|
895
Travere Therapeutics
TVTX
$1.93B
| $26K | ﹤0.01% |
+1,448
| New | +$26K |
|
896
Apogee Therapeutics
APGE
$2.26B
| $25K | ﹤0.01% |
+681
| New | +$25K |
|
897
AvePoint
AVPT
$3.45B
| $25K | ﹤0.01% |
+1,735
| New | +$25K |
|
898
Riot Platforms
RIOT
$4.91B
| $25K | ﹤0.01% |
+3,444
| New | +$25K |
|
899
Asana
ASAN
$3.18B
| $23K | ﹤0.01% |
+1,597
| New | +$23K |
|
900
Vertex
VERX
$3.83B
| $22K | ﹤0.01% |
+641
| New | +$22K |
|